Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $470.5800 (-2.39%) ($469.3900 - $470.5800) on Tue. Mar. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.74% (three month average) | RSI | 53 | Latest Price | $470.5800(-2.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -0.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(42%) DIA(36%) SPLV(36%) IVW(35%) | Factors Impacting REGN price | REGN will decline at least -0.87% in a week (0% probabilities). VIXM(-20%) UUP(-7%) TBT(-6%) VXX(-5%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.87% (StdDev 1.74%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $471.37 | 5 Day Moving Average | $470.52(0.01%) | 10 Day Moving Average | $474.86(-0.9%) | 20 Day Moving Average | $471.37(-0.17%) | To recent high | -14.3% | To recent low | 5.4% | Market Cap | $49.895b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |